Fidelity in functional coupling of the rat P2Y 1 receptor to phospholipase C

• Published in: British journal of pharmacology 2009-02, Vol.122 (6), p.1021-1024
• Main Authors: Schachter, Joel B., Boyer, José L., Li, Qing, Nicholas, Robert A., Harden, T. Kendall
• Format: Article
• Language: English
• ISSN: 0007-1188; 1476-5381
• DOI: 10.1038/sj.bjp.0701479

The rat homologue of the P2Y 1 receptor has been heterologously expressed in 1321N1 human astrocytoma cells and in C6 rat glioma cells. As has been shown previously for the turkey and human P2Y 1 receptors, the rat P2Y 1 receptor expressed in either cell type responded to 2MeSATP with increases in inositol phosphate accumulation that were competitively blocked by the antagonist PPADS. Neither of the wild type cell lines exhibited inositol phosphate responses to P2Y 1 receptor agonists. Expression of the rat P2Y 1 receptor did not confer a capacity of 2MeSATP to inhibit adenylyl cyclase activity in 1321N1 cells. Moreover, the inhibition of adenylyl cyclase mediated by an endogenous P2Y receptor of C6 glioma cells was not enhanced by expression of the rat P2Y 1 receptor. The P2Y receptor‐mediated inhibition of adenylyl cyclase in C6 glioma cells expressing both the endogenous P2Y receptor and the rat P2Y 1 receptor remained unaffected by PPADS. Since the P2Y receptor responsible for inhibition of adenylyl cyclase in C6 glioma cells does not share the pharmacological or functional properties of the P2Y 1 receptor, even when both receptors originate from the same species and are simultaneously expressed in the same cell line, it is concluded that the P2Y 1 receptor is distinct from an endogenous P2Y receptor in C6 cells that couples to inhibition of adenylyl cyclase. British Journal of Pharmacology (1997) 122 , 1021–1024; doi: 10.1038/sj.bjp.0701479